2022
DOI: 10.1016/j.cardfail.2022.03.358
|View full text |Cite
|
Sign up to set email alerts
|

Baseline Quality-of-Life of Caregivers of Patients With Heart Failure Prior to Advanced Therapies: Findings From the Sustaining Quality of Life of the Aged: Transplant or Mechanical Support (SUSTAIN-IT) Study

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 46 publications
0
2
0
Order By: Relevance
“…Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support (SUSTAIN-IT) is a National Institute on Aging–funded study of patients with heart failure aged 60 to 80 years who undergo heart transplantation or long-term LVAD implantation, when ineligible for transplant, and their caregivers 23 . Patient and caregiver inclusion and exclusion criteria for SUSTAIN-IT have been described previously 24,25 . For this report from SUSTAIN-IT, patients with advanced heart failure were included if they were scheduled to undergo long-term LVAD implantation with a second- or third-generation Food and Drug Administration–approved or investigational LVAD 23 .…”
Section: Methodsmentioning
confidence: 99%
See 1 more Smart Citation
“…Sustaining Quality of Life of the Aged: Heart Transplant or Mechanical Support (SUSTAIN-IT) is a National Institute on Aging–funded study of patients with heart failure aged 60 to 80 years who undergo heart transplantation or long-term LVAD implantation, when ineligible for transplant, and their caregivers 23 . Patient and caregiver inclusion and exclusion criteria for SUSTAIN-IT have been described previously 24,25 . For this report from SUSTAIN-IT, patients with advanced heart failure were included if they were scheduled to undergo long-term LVAD implantation with a second- or third-generation Food and Drug Administration–approved or investigational LVAD 23 .…”
Section: Methodsmentioning
confidence: 99%
“…23 Patient and caregiver inclusion and exclusion criteria for SUSTAIN-IT have been described previously. 24,25 For this report from SUSTAIN-IT, patients with advanced heart failure were included if they were scheduled to undergo long-term LVAD implantation with a second-or third-generation Food and Drug Administration-approved or investigational LVAD. 23 Long-term LVAD implant was defined as not listed for heart transplantation at the time of implantation and having a low probability of transplant (<35% at 2 years) in the site investigator's opinion.…”
Section: Study Populationmentioning
confidence: 99%